NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rymedi

Rymedi

Private
Greenville, South CarolinaHealthcare & Life Scienceshttp://www.rymedi.com/

Last Round

Series A

Oct 25, 2023

Total Funding Raised

$17M

Company Overview

Rymedi is a healthcare technology company that provides a blockchain-secured data exchange platform for diagnostic testing, clinical trials, and occupational health.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Pharma Supply Chain, Data Governance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

clinical trial managementsupply chain traceabilityhealthcare data managementblockchain for healthcarediagnostic reportingDrug Supply Chain Security ActDSCSAclinical research organizationCROdata interoperabilitypharma supply chainhealth techdigital health platformregulatory compliance softwareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rymedi Comparables

Compare Rymedi with similar companies based on industry and business-model similarity.

Rymedi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Triall
81%
Chronicled
76%
Embleema
76%

Rymedi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 25, 2023
DebtMay 1, 2020

Key People

Founding team and executive leadership

Jason Cross

Co-Founder Chief Strategy Officer

Founding Team

Rymedi Investors

Notable investors and investment history

Rymedi investors
InvestorRounds
White Star CapitalSeries A
FoundervilleSeed
Catalytic Impact FoundationSeed
Raptor DigitalSeries A
Blockchange VenturesSeries A
RW3 VenturesSeries A

Rymedi Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rymedi Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rymedi's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreenville, South Carolina
Employee Range11
Year Founded2018
Last FundingOct 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.